Michael Gaba

Comparable Alternatives, Cost Effectiveness, and Clinical Trial Data: The Medicare Prescription Drug Bill Changes the Reimbursement Landscape

Federal Regulation in the Absence of Prescription Drug Legislation: The Bush Administration´s Proposal to Speed Generics to Market

Federal Government Proposes Modifications to Final Privacy Rules

OIG Releases Five New Advisory Opinions

Developing Integrated Product Approval And Reimbursement Strategies In The Absence Of Clear Rules